gpASIT+™
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for gpASIT+™, covering 2018-10-11 to 2018-10-30. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis [Phase 3]